Avantax Planning Partners’s Precigen PGEN Stock Holding History

Avantax Planning Partners’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-25	Closed	–	–	1126
2018 Q1	$0	Buy	+25	New	+$357	﹤0.01%	1854

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Avantax Planning Partners's PGEN Position: Q2 2018 in Review

Avantax Planning Partners sold out of Precigen (PGEN) in Q2 2018, closing a stake of 25 shares.

Avantax Planning Partners first reported a position in PGEN in Q1 2018 and held it in 1 quarter. The position peaked at $0 in Q1 2018. 166 funds tracked by Wall St. Rank hold PGEN as of Q2 2018.

Avantax Planning Partners reported no remaining Precigen position as of Q2 2018 after selling out during the quarter.
Avantax Planning Partners sold 25 Precigen shares in Q2 2018.
Avantax Planning Partners first reported a position in Precigen in Q1 2018 and held it in 1 quarter.
Avantax Planning Partners's Precigen position peaked at $0 in Q1 2018.
166 funds tracked by Wall St. Rank held Precigen as of Q2 2018.

Based on Avantax Planning Partners's 13F filing for Q2 2018, filed 13 Aug 2018.